Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
 /Â
Avrobio
Avrobio
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Avrobio
Stock Price
$1.4
2024-06-21
Market Capitalization
$5.2 M
2024-06-21
Avrobio Summary
Company Summary
Overview
Gene therapy has the potential to deliver dramatic disease modifying effects and potentially life-long cures from a single infusion of genetically-modified cells.
Type
Public
Status
Active
HQ
Cambridge, MA, US
|
view all locations
Website
http://www.avrobio.com/
Cybersecurity rating
ESG rating
40-49 out of 100
|
View all ESG data
Sectors
Healthcare
biotech
genetics
healthtech
Homepage
Linkedin
twitter
Table of Contents
Key People
Locations
Financials
Competitors
Key People
Geoff MacKay,
President, CEO and Director
Linkedin
Erik Ostrowski,
Chief Financial Officer
Linkedin
Azadeh Golipour,
Chief Technology Officer
Linkedin
Deanna Petersen,
Chief Business Officer
Linkedin
and 18 others
Locations
View all
1 location detected
Cambridge, MAÂ
HQ
United States
One Kendall Square Building 300 Suite 201
Report incorrect company information
Avrobio Financials
Summary Financials
Net income (Q1, 2025)
($15.9M)
Cash (Q1, 2025)
$306.2M
EBIT (Q1, 2025)
($18.3M)
Enterprise value
($298.8M)
Competitors and Similar Companies
Othram
Technology - Private
Senti Biosciences
Healthcare - Public
Science
Healthcare - Private
Codex DNA
Healthcare - Public
Compare competitors
Footer menu
Contact us
Facebook
Twitter
LinkedIn
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2025
Share price data provided by IEX
Back
to top